BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 20395666)

  • 21. Endocrine abnormalities in patients with Fanconi anemia.
    Giri N; Batista DL; Alter BP; Stratakis CA
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2624-31. PubMed ID: 17426088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy and safety of long-term Norditropin® treatment in children with Prader-Willi syndrome.
    Meinhardt U; Christiansen JS; Farholt S; Lämmer C; Ostergaard JR; Schmidt F; Kappelgaard AM; Eiholzer U
    Horm Metab Res; 2013 Jul; 45(7):532-6. PubMed ID: 23632904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of body composition, basal metabolic rate and metabolic outcomes of adults with Prader Willi syndrome or lesional hypothalamic disease, with primary obesity.
    Lloret-Linares C; Faucher P; Coupaye M; Alili R; Green A; Basdevant A; Clément K; Poitou C
    Int J Obes (Lond); 2013 Sep; 37(9):1198-203. PubMed ID: 23318724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation (TIF).
    De Sanctis V; Eleftheriou A; Malaventura C;
    Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():249-55. PubMed ID: 16462705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prader-Willi syndrome.
    Landwirth J; Schwartz AH; Grunt JA
    Am J Dis Child; 1968 Aug; 116(2):211-7. PubMed ID: 5659301
    [No Abstract]   [Full Text] [Related]  

  • 26. Prader Willi Syndrome: Genetics, Metabolomics, Hormonal Function, and New Approaches to Therapy.
    Irizarry KA; Miller M; Freemark M; Haqq AM
    Adv Pediatr; 2016 Aug; 63(1):47-77. PubMed ID: 27426895
    [No Abstract]   [Full Text] [Related]  

  • 27. Urinary incontinence in persons with Prader-Willi Syndrome.
    Von Gontard A; Didden R; Sinnema M; Curfs L
    BJU Int; 2010 Dec; 106(11):1758-62. PubMed ID: 20575983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scoliosis in patients with Prader-Willi Syndrome.
    Odent T; Accadbled F; Koureas G; Cournot M; Moine A; Diene G; Molinas C; Pinto G; Tauber M; Gomes B; de Gauzy JS; Glorion C
    Pediatrics; 2008 Aug; 122(2):e499-503. PubMed ID: 18606625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scoliosis and BMI in patients with Prader-Willi syndrome.
    Tsai LP; Tzeng ST; Hsieh TH; Li YC; Hung SS
    J Pediatr Orthop B; 2023 Nov; 32(6):524-530. PubMed ID: 36445375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Glucose intolerance in obese children and adolescents].
    Yeste D; Betancourth S; Gussinyé M; Potau N; Carrascosa A
    Med Clin (Barc); 2005 Oct; 125(11):405-8. PubMed ID: 16216184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth hormone treatment completely normalizes adult height and improves body composition in Prader-Willi syndrome: experience from KIGS (Pfizer International Growth Database).
    Lindgren AC; Lindberg A
    Horm Res; 2008; 70(3):182-7. PubMed ID: 18663319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Self-induced cutaneous lesions in Prader-Willi syndrome].
    Plantin P; Milochau P; Broussine L; Blondin G
    Ann Dermatol Venereol; 1997; 124(5):390-2. PubMed ID: 9739896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
    Feigerlová E; Diene G; Oliver I; Gennero I; Salles JP; Arnaud C; Tauber M
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased leptin messenger RNA and serum leptin levels in children with Prader-Willi syndrome and nonsyndromal obesity.
    Lindgren AC; Marcus C; Skwirut C; Elimam A; Hagenäs L; Schalling M; Anvret M; Lönnqvist F
    Pediatr Res; 1997 Nov; 42(5):593-6. PubMed ID: 9357929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyroid function from birth to adolescence in Prader-Willi syndrome.
    Sharkia M; Michaud S; Berthier MT; Giguère Y; Stewart L; Deladoëy J; Deal C; Van Vliet G; Chanoine JP
    J Pediatr; 2013 Sep; 163(3):800-5. PubMed ID: 23623517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperghrelinemia precedes obesity in Prader-Willi syndrome.
    Feigerlová E; Diene G; Conte-Auriol F; Molinas C; Gennero I; Salles JP; Arnaud C; Tauber M
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2800-5. PubMed ID: 18460565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary testicular dysfunction is a major contributor to abnormal pubertal development in males with Prader-Willi syndrome.
    Hirsch HJ; Eldar-Geva T; Benarroch F; Rubinstein O; Gross-Tsur V
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2262-8. PubMed ID: 19401370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testicular histology in boys with Prader-Willi syndrome: fertile or infertile?
    Vogels A; Moerman P; Frijns JP; Bogaert GA
    J Urol; 2008 Oct; 180(4 Suppl):1800-4. PubMed ID: 18721940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular and metabolic risk profile and acylation-stimulating protein levels in children with Prader-Willi syndrome and effects of growth hormone treatment.
    de Lind van Wijngaarden RF; Cianflone K; Gao Y; Leunissen RW; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1758-66. PubMed ID: 20173020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age at diagnosis, body mass index and physical morbidity in children and adults with the Prader-Willi syndrome.
    Vogels A; Fryns JP
    Genet Couns; 2004; 15(4):397-404. PubMed ID: 15658614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.